Aurora Cannabis Inc. · TSX:ACB
Aurora Cannabis — Q2 2023 Earnings Presentation
6 slides from Aurora Cannabis's earnings presentation, Feb 9, 2023
Slide 1: Fiscal Q2 2023 Supplemental Information
FISCAL Q2 2023 SUPPLEMENTAL INFORMATION FEBRUARY 2023
Slide 2: Disclaimer
Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information contained in this presentation constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this presentation that are not statements of historical fact may be deemed
Slide 3: Key Takeaways
Key Takeaways Opening the Remain #1 Canadian LP in global medical cannabis revenues World to Significant growth opportunities in high margin domestic and international medical cannabis segments Cannabis Achievement of Achieved Adjusted EBITDA profitability for quarter ending December 31, 2022
Slide 4: FY23 Q2 Key Financial Highlights
FY23 Q2 Key Financial Highlights • Strong Canadian Medical Performance • #1 market share with strong and consistent margins • Direct-to-patient model bypasses provincial distributor • Technology investment drives high and repeatable margin and Canadian Plant creates barrier to new entrants Int’l Med
Slide 5: FY23 Q2 Key Financial Trends
FY23 Q2 Key Financial Trends Metric FY23 Q2 FY23 Q1 QoQ Improvement (%) Total cannabis net revenue (1) $55.0m $46.0m 20% Adjusted Gross Profit Before $27.6m $24.4m 13% Fair Value Adjustments (1) SG&A and R&D excluding restructuring, non-recurring, $26.6m $32.1m 15% out of period and market developme
Slide 6: Investor Presentation
INVESTOR PRESENTATION Email: aurora@icrinc.com Website: investor.auroramj.com